HTL Biotechnology inaugurates a new production line dedicated to sterile Hyaluronic Acid
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.
Early this year, HTL Biotechnology had committed to celebrating the 90th Anniversary of HA throughout the year 2024. Today, as the celebration goes on, it is with great enthusiasm that we announce the launch of a new, dedicated webpage to commemorate the 90th anniversary of the discovery of Hyaluronic Acid.
This new webpage will feature the fascinating journey of HA and introduce our newly launched White Paper.
#90yearsofHAwithHTL
On October 28, 2025, HTL Biotechnology hosted its first-ever webinar, “Shaping the Future of Aesthetic Medicine with Premium Biopolymers,” a key initiative to strengthen our presence in Asia and promote the “Feel the Difference with HTL Inside” positioning among major players in aesthetic medicine.
This October, HTL Biotechnology turned pink to support breast cancer prevention.
HTL Biotechnology is the winner of the Responsible Care West Atlantic Trophy in the ‘Energy – Climate’ category for its project to reduce carbon emissions from distillation systems.